NEUROONE MEDICAL TECHNOLOGIES Corp
NMTCNasdaqCIK 1500198HealthcareFiscal year ends Sep 30
Reports and events: 260 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0513:20 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-106677 |
| 2026-08-2713:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-094174 |
| 2026-08-1312:20 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-088724 |
| 2026-08-1312:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-088719 |
| 2026-06-1220:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-068327 |
| 2026-06-1220:32 ET | 10-Q/A | Quarterly report, amendedPeriod 2026-03-31 | 0001213900-26-068307 |
| 2026-05-2220:30 ET | 8-K | 4.02 Non-reliance on financial statements; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-060600 |
| 2026-05-1212:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-054749 |
| 2026-05-1212:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-054744 |
| 2026-05-0412:30 ET | 8-K | 8.01 Other events | 0001213900-26-051158 |
| 2026-04-3012:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-049748 |
| 2026-04-1412:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-043239 |
| 2026-04-0320:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-039992 |
| 2026-03-0912:00 ET | DEF 14A | Proxy statementPeriod 2026-04-03 | 0001213900-26-024927 |
| 2026-02-2521:30 ET | 8-K | 8.01 Other events | 0001213900-26-020400 |
| 2026-02-1713:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-016912 |
| 2026-02-1712:01 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001213900-26-016860 |
| 2026-01-2321:30 ET | 10-K/A | Annual report, amendedPeriod 2025-09-30 | 0001213900-26-007245 |
| 2025-12-2213:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-124165 |
| 2025-12-1713:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-122541 |
| 2025-12-1723:05 ET | 10-K | Annual reportPeriod 2025-09-30 | 0001213900-25-122390 |
| 2025-11-0513:54 ET | 8-K | 3.01 Delisting notice | 0001213900-25-106454 |
| 2025-10-0620:19 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-096548 |
| 2025-08-1812:42 ET | 8-K | 8.01 Other events | 0001213900-25-077726 |
| 2025-08-1520:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-077511 |
| 2025-08-1412:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-076080 |
| 2025-08-1411:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-076039 |
| 2025-05-1312:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-042270 |
| 2025-05-1312:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-042266 |
| 2025-05-0920:30 ET | 8-K | 3.01 Delisting notice | 0001213900-25-041554 |
| 2025-04-0720:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-029442 |
| 2025-02-2021:15 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-015683 |
| 2025-02-1421:15 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-014281 |
| 2025-02-1213:30 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001213900-25-012511 |
| 2025-02-1213:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-012510 |
| 2025-02-0421:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-010083 |
| 2025-01-2121:15 ET | DEF 14A | Proxy statementPeriod 2025-02-14 | 0001213900-25-005016 |
| 2025-01-1413:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-003166 |
| 2025-01-1022:04 ET | 8-K | 3.01 Delisting notice | 0001213900-25-002728 |
| 2025-01-1014:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-002381 |
| 2024-12-1713:40 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-109529 |
| 2024-12-1713:29 ET | 10-K | Annual reportPeriod 2024-09-30 | 0001213900-24-109524 |
| 2024-11-0821:30 ET | 8-K | 1.02 Termination of a material agreement | 0001213900-24-095934 |
| 2024-10-3120:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-092879 |
| 2024-09-1320:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-078584 |
| 2024-08-1420:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-069036 |
| 2024-08-1412:59 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-068633 |
| 2024-08-0720:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-24-066142 |
| 2024-07-1220:49 ET | 8-K | 3.01 Delisting notice | 0001213900-24-061064 |
| 2024-06-2120:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-24-054782 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.